First Republic Investment Management, Inc. Revance Therapeutics, Inc. Transaction History
First Republic Investment Management, Inc.
- $34.7 Billion
- Q3 2023
A detailed history of First Republic Investment Management, Inc. transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 54,329 shares of RVNC stock, worth $139,625. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54,329
Previous 54,126
0.38%
Holding current value
$139,625
Previous $1.37 Million
54.49%
% of portfolio
0.0%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding RVNC
# of Institutions
196Shares Held
81.5MCall Options Held
490KPut Options Held
128K-
Capital World Investors Los Angeles, CA13.9MShares$35.8 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.57MShares$22 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA6.26MShares$16.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.99MShares$15.4 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA5.26MShares$13.5 Million1.71% of portfolio
About Revance Therapeutics, Inc.
- Ticker RVNC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,305,696
- Market Cap $212M
- Description
- Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...